课题基金 / 基金详情

Neutraceuticals and diabetes: Nrf-2 activation is a critical mechanism underlying the effect of certain plant-derived compounds in preventing insulin resistance.

Neutraceuticals and diabetes: Nrf-2 activation is a critical mechanism underlying the effect of certain plant-derived compounds in preventing insulin resistance.
营养保健品和糖尿病:Nrf-2 激活是某些植物源化合物预防胰岛素抵抗作用的关键机制。
批准号:
262838
负责人:
Fantus Ivan G
金额:
$16.39万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2012
资助国家:
加拿大
项目状态:
已结题
起止时间:
2012-05-01 至 2015-05-01

项目摘要

项目成果

Fantus Ivan G的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The rates of diabetes are increasing worldwide and along with this, the associated complications consisting of kidney, eye and cardiovascular diseases. While the cause of diabetes is not completely understood, a major factor is overnutrition (poor diet) a
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel mediators of thioredoxin-interacting protein in diabetes complications.
Tyrosine kinase signaling in the pathogenesis of diabetic nephropathy.
  • 批准号:
    292894
  • 项目类别:
    Operating Grants
  • 资助金额:
    $23.96万
  • 财政年份:
    2013
  • 负责人:
    Fantus Ivan G
  • 依托单位:
The role of TxNIP in the development of diabetic nephropathy.
  • 批准号:
    231159
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2011
  • 负责人:
    Fantus Ivan G
  • 依托单位:
Interactions between cGMP and insulin cell signaling pathways: Physiology and molecular mechanisms of regulation of insulin sensitivity.
  • 批准号:
    180702
  • 项目类别:
    Operating Grants
  • 资助金额:
    $26.58万
  • 财政年份:
    2009
  • 负责人:
    Fantus Ivan G
  • 依托单位:
海外基金